Planta Med 2014; 80(02/03): 146-152
DOI: 10.1055/s-0033-1360197
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

The Total Phenolic Fraction of Anemarrhena asphodeloides Inhibits Inflammation and Reduces Insulin Resistance in Adipocytes via Regulation of AMP-Kinase Activity

Wenjun Zhao
1   Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China
,
Meng Wang
2   Biomedical Sciences, Institute of Chinese Medical Sciences, University of Macau, Macao, China
,
Lu Shao
1   Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China
,
Min Liao
1   Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China
,
Kang Liu
1   Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China
,
Fang Huang
1   Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China
,
Baolin Liu
1   Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China
› Author Affiliations
Further Information

Publication History

received 07 August 2013
revised 26 November 2013

accepted 28 November 2013

Publication Date:
15 January 2014 (online)

Abstract

Anemarrhena asphodeloides is widely used for treatment of metabolic disorders in traditional Chinese medicine. This study investigated the effects of the total phenolic fraction of Anemarrhena asphodeloides on regulation of insulin sensitivity in adipocytes. Through treatment with macrophage-derived conditioned medium, insulin resistance was induced in adipocytes with IKKβ activation and dysregulation of adipokine production. However, these changes were reversed by treatment with the total phenolic fraction of A. asphodeloides (1, 10, 50 µg/mL). It regulated serine/tyrosine phosphorylation of insulin receptor substrate-1 and subsequently restored Akt phosphorylation in response to insulin, thereby leading to the improvement of insulin-mediated glucose uptake. The total phenolic fraction of A. asphodeloides enhanced AMP-activated protein kinase phosphorylation, and this action contributed to the inhibition of inflammation implicated in insulin resistance. In conclusion, the total phenolic fraction of A. asphodeloides attenuated insulin resistance in adipocytes by inhibition of inflammation in an AMP-activated protein kinase-dependent manner.

Supporting Information

 
  • References

  • 1 Harris MI, Flegal KM, Cowie CC, Ebehardt MS, Goldsteein DE, Little RR, Woedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third National Health and Nutrition Examination Survey, 1988–1994. Diabet Care 1998; 21: 518-524
  • 2 Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867
  • 3 Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005; 87: 99-109
  • 4 Lihn AS, Jessen N, Pedersen SB, Lund S, Richelsen B. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem Biophys Res Commun 2004; 316: 853-858
  • 5 Galic S, Fullerton MD, Schertzer JD, Sikkema S, Marcinko K, Walkley CR, Lzon D, Honeyman J, Chen ZP, van Denderen BJ, Kemp BE, Steinberg GR. Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 2011; 121: 4903-4915
  • 6 Gauthier MS, OʼBrien EL, Bigornia S, Mott M, Cacicedo JM, Xu XJ, Gokce N, Apovian C, Ruderman N. Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 2011; 404: 382-387
  • 7 Yang Z, Kahn BB, Shi H, Xue BZ. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem 2010; 285: 19051-19059
  • 8 Xie W, Zhao Y, Zhang Y. Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus. Evid Based Complement Alternat Med 2011; 2011: 726723
  • 9 Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, Sasaki H, Okada M, Ishida T, Seino Y, Tanigawa K. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biol Pharm Bull 2001; 24: 1009-1011
  • 10 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91
  • 11 Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity and diet induced insulin resistance with salicylates or targeted disruption of IKKβ . Science 2001; 293: 1673-1677
  • 12 Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1220-R1225
  • 13 Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie DG. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 2012; 336: 918-922
  • 14 Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-26058
  • 15 Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKKβ and NF-κB. Nat Med 2005; 11: 183-190
  • 16 Liu K, Luo T, Zhang Z, Wang T, Kou J, Liu B, Huang F. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway. J Ethnopharmacol 2011; 136: 473-479
  • 17 Salama RM, Schaalan MF, Elkoussi AA, Khalifa AE. Potential utility of sodium selenate as an adjunct to metformin in treating type II diabetes mellitus in rats: a perspective on protein tyrosine phosphatase. Biomed Res Int 2013; 2013: 231378